Eli Lilly Loses Patent Lawsuit For Drug Strattera

INDIANAPOLIS - (AP) Eli Lilly & Co. on Thursday lowered its revenue outlook for the year after it lost a patent lawsuit over its attention deficit hyperactivity drug Strattera. The U.S. District Court for the District of New Jersey ruled against the company, saying its method-of-use patent. . . ...